||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Tristel Share Discussion Threads
Showing 2476 to 2499 of 2500 messages
|Piedro should go and give them a hard time :-)
|Investors day with trading update being planned for June it seems. Anyone here going?Regards,Source.|
|Some competition ...
Uniwipe Clinical Sanitising Wipes
Uniwipe Clinical Sanitising Wipes are our largest, strongest and most powerful wipes.
Supersize and heavy-duty, they’re made from low-lint, micro-fibre fabric, able to trap dirt and kill bacteria. As a result, they leave every surface safe and grime-free. What’s more, the unique formula of these wipes means they are fast acting and effective on even the most challenging clinical environment.
|hoping for a trading update this week...|
|In short ...
A good company, but the management needs watching ...
... and they need that new chairman to keep their ambitions under control
OR must we wait till they lose their 'marbles' again
... and blame it on "expectations not being met"
As the saying goes, 'the casino always wins'
|Apad - share data from Stockopedia|
I have to slaughter goats like everyone else :-)
I calculate a Price/free cash flow per share of 30. Which makes it look pricier than the PERs (19 and 22 bwd and fwd).|
|APAD - your post 1889 - clairvoyant?
Anyhow here is today's RNS
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that Francisco Soler, Chairman of the Company, yesterday purchased 12,325 ordinary shares of 1p each ("Ordinary Shares") in the Company at 114.5p pence each. Following this purchase, he holds 10,913,834 Ordinary Shares, representing 25.9% of the issued share capital. This holding includes family and related corporate vehicles.|
Where did the data come from?
Shares in issue from 2009 to 2014
Average Shares m 34.9 37.5 39.5 38.1 40.6 44.1|
|Moves mountains, I am told :-)
There I go being flippant again!
Does anyone know where I can get historic data on shares in issue?|
|Bought a few more this morning. As I first got in at 28p there's not too much risk to my capital and I think (believe? have faith?) that this company has quite a bit further to go|
|Faith: a belief not based on proof. Mmmm.
Anyway bought a few more this morning.
I reckon these prices are good without the y'oodlles.
|Just some patience needed APAD. I think the buys show some faith in the company and that we are probably undervalued now. If the breakthrough into the US comes there will be an enormous market and first mover advantage. Disenchanted sellers may well come to regret their sales.|
|Swinney buys 5k shares today. Goodness me. Soler tomorrow no doubt :-)
The O shareholders are selling pretty regularly - disenchanted I guess.
|Increased again at 114.
Time to stop now.
|Increased today at 116, despite new IT manager.
|Tristel has a new IT & Systems Manager since August 2014
To see what he has been doing - look him up on LinkedIn
“We wanted to control our costs and deliver a consistent IT experience across our international sites. The Zynstra solution allows us to deliver the IT our branches need, with centralized control.”
Tim Newton, IT & Systems Manager
|...and hopefully the management suitably chastened not to raid shareholders money in such a barefaced way anytime soon.
|China's endoscopy market poised for growth -
and from 24th Feb TSTL half yearly report
China & Hong Kong (subsidiary) sales up from £286k to £486k H1 2014 to H1 2015
|see page 10 of
for this prediction of a 75% increase over the next five years - UK -
It has been calculated through Department of Health
modelling on lower GI endoscopy demand, that in the
next five years, endoscopy units will need to increase
their capacity by around 10-15% year on year. Overall
this may equate to around a 75% increase in total.|
|You are something of a star, Piedro.
|Capital Radiology find compliance, speed and efficacy with Tristel
As clinical managers within one of Australia’s busiest and fastest growing Medical Imaging providers, Capital Radiology’s Omar Ameen and Angus Richmond saw the need to standardise the company’s ultrasound probe disinfection method.
"I looked at all the positives and negatives of different products and to be honest Tristel was initially the underdog, having only recently become available in Australia.”
Samples and information were taken back to sonographers at Capital Radiology and it was decided for all clinics to start using the Tristel Trio Wipes System for the decontamination of ultrasound probes.
“To date, we haven’t found anything that matches the Tristel Trio Wipes System”, says Angus.“We quickly moved away from the solutions and systems we had been using."